nodes	percent_of_prediction	percent_of_DWPC	metapath
Fidaxomicin—ABCB1—ovarian cancer	0.592	1	CbGaD
Fidaxomicin—ABCB1—Topotecan—ovarian cancer	0.112	0.354	CbGbCtD
Fidaxomicin—ABCB1—Vinorelbine—ovarian cancer	0.0791	0.249	CbGbCtD
Fidaxomicin—ABCB1—Paclitaxel—ovarian cancer	0.0556	0.175	CbGbCtD
Fidaxomicin—ABCB1—Docetaxel—ovarian cancer	0.0402	0.127	CbGbCtD
Fidaxomicin—ABCB1—Doxorubicin—ovarian cancer	0.03	0.0945	CbGbCtD
Fidaxomicin—Intestinal obstruction—Topotecan—ovarian cancer	0.00251	0.0277	CcSEcCtD
Fidaxomicin—Anaemia—Altretamine—ovarian cancer	0.00218	0.0241	CcSEcCtD
Fidaxomicin—Intestinal obstruction—Vinorelbine—ovarian cancer	0.00214	0.0237	CcSEcCtD
Fidaxomicin—Decreased appetite—Altretamine—ovarian cancer	0.00167	0.0185	CcSEcCtD
Fidaxomicin—Intestinal obstruction—Paclitaxel—ovarian cancer	0.00144	0.016	CcSEcCtD
Fidaxomicin—Dizziness—Altretamine—ovarian cancer	0.00127	0.0141	CcSEcCtD
Fidaxomicin—Vomiting—Altretamine—ovarian cancer	0.00122	0.0135	CcSEcCtD
Fidaxomicin—Intestinal obstruction—Docetaxel—ovarian cancer	0.00122	0.0135	CcSEcCtD
Fidaxomicin—Nausea—Altretamine—ovarian cancer	0.00114	0.0127	CcSEcCtD
Fidaxomicin—Neutropenia—Chlorambucil—ovarian cancer	0.00113	0.0125	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Topotecan—ovarian cancer	0.00109	0.0121	CcSEcCtD
Fidaxomicin—Neutropenia—Topotecan—ovarian cancer	0.001	0.0111	CcSEcCtD
Fidaxomicin—Neutropenia—Melphalan—ovarian cancer	0.000981	0.0109	CcSEcCtD
Fidaxomicin—Dysphagia—Vinorelbine—ovarian cancer	0.000917	0.0101	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Topotecan—ovarian cancer	0.000904	0.01	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Melphalan—ovarian cancer	0.000885	0.00979	CcSEcCtD
Fidaxomicin—Neutropenia—Vinorelbine—ovarian cancer	0.000857	0.00948	CcSEcCtD
Fidaxomicin—Anaemia—Chlorambucil—ovarian cancer	0.000775	0.00858	CcSEcCtD
Fidaxomicin—Immune system disorder—Topotecan—ovarian cancer	0.000775	0.00857	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Vinorelbine—ovarian cancer	0.000773	0.00855	CcSEcCtD
Fidaxomicin—Angioedema—Chlorambucil—ovarian cancer	0.000766	0.00848	CcSEcCtD
Fidaxomicin—Immune system disorder—Melphalan—ovarian cancer	0.000759	0.00839	CcSEcCtD
Fidaxomicin—Malnutrition—Topotecan—ovarian cancer	0.000747	0.00826	CcSEcCtD
Fidaxomicin—Anaemia—Topotecan—ovarian cancer	0.00069	0.00764	CcSEcCtD
Fidaxomicin—Angioedema—Topotecan—ovarian cancer	0.000682	0.00755	CcSEcCtD
Fidaxomicin—Anaemia—Melphalan—ovarian cancer	0.000676	0.00748	CcSEcCtD
Fidaxomicin—Immune system disorder—Vinorelbine—ovarian cancer	0.000663	0.00733	CcSEcCtD
Fidaxomicin—Malnutrition—Vinorelbine—ovarian cancer	0.000639	0.00707	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.000631	0.00699	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Paclitaxel—ovarian cancer	0.000629	0.00696	CcSEcCtD
Fidaxomicin—Abdominal distension—Paclitaxel—ovarian cancer	0.000621	0.00687	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.000618	0.00684	CcSEcCtD
Fidaxomicin—Dysphagia—Paclitaxel—ovarian cancer	0.000617	0.00682	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Docetaxel—ovarian cancer	0.000605	0.00669	CcSEcCtD
Fidaxomicin—Dyspepsia—Chlorambucil—ovarian cancer	0.000602	0.00667	CcSEcCtD
Fidaxomicin—Nervous system disorder—Topotecan—ovarian cancer	0.000598	0.00661	CcSEcCtD
Fidaxomicin—Decreased appetite—Chlorambucil—ovarian cancer	0.000595	0.00658	CcSEcCtD
Fidaxomicin—Skin disorder—Topotecan—ovarian cancer	0.000592	0.00655	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.000591	0.00654	CcSEcCtD
Fidaxomicin—Anaemia—Vinorelbine—ovarian cancer	0.00059	0.00653	CcSEcCtD
Fidaxomicin—Angioedema—Vinorelbine—ovarian cancer	0.000584	0.00646	CcSEcCtD
Fidaxomicin—Skin disorder—Melphalan—ovarian cancer	0.00058	0.00641	CcSEcCtD
Fidaxomicin—Neutropenia—Paclitaxel—ovarian cancer	0.000576	0.00638	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00056	0.00619	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Paclitaxel—ovarian cancer	0.000556	0.00615	CcSEcCtD
Fidaxomicin—Dyspnoea—Topotecan—ovarian cancer	0.000543	0.00601	CcSEcCtD
Fidaxomicin—Abdominal pain—Chlorambucil—ovarian cancer	0.000541	0.00599	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.00054	0.00598	CcSEcCtD
Fidaxomicin—Dyspepsia—Topotecan—ovarian cancer	0.000536	0.00594	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Docetaxel—ovarian cancer	0.000533	0.0059	CcSEcCtD
Fidaxomicin—Dyspnoea—Melphalan—ovarian cancer	0.000532	0.00589	CcSEcCtD
Fidaxomicin—Decreased appetite—Topotecan—ovarian cancer	0.00053	0.00586	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000526	0.00582	CcSEcCtD
Fidaxomicin—Dyspepsia—Melphalan—ovarian cancer	0.000525	0.00581	CcSEcCtD
Fidaxomicin—Dysphagia—Docetaxel—ovarian cancer	0.000523	0.00578	CcSEcCtD
Fidaxomicin—Constipation—Topotecan—ovarian cancer	0.000521	0.00577	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Paclitaxel—ovarian cancer	0.00052	0.00575	CcSEcCtD
Fidaxomicin—Decreased appetite—Melphalan—ovarian cancer	0.000519	0.00574	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000515	0.0057	CcSEcCtD
Fidaxomicin—Nervous system disorder—Vinorelbine—ovarian cancer	0.000511	0.00566	CcSEcCtD
Fidaxomicin—Skin disorder—Vinorelbine—ovarian cancer	0.000506	0.0056	CcSEcCtD
Fidaxomicin—Hypersensitivity—Chlorambucil—ovarian cancer	0.000504	0.00558	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Topotecan—ovarian cancer	0.000498	0.00551	CcSEcCtD
Fidaxomicin—Neutropenia—Docetaxel—ovarian cancer	0.000489	0.00541	CcSEcCtD
Fidaxomicin—Pruritus—Chlorambucil—ovarian cancer	0.000484	0.00536	CcSEcCtD
Fidaxomicin—Abdominal pain—Topotecan—ovarian cancer	0.000482	0.00533	CcSEcCtD
Fidaxomicin—Dyspnoea—Vinorelbine—ovarian cancer	0.000465	0.00514	CcSEcCtD
Fidaxomicin—Decreased appetite—Vinorelbine—ovarian cancer	0.000453	0.00501	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00045	0.00498	CcSEcCtD
Fidaxomicin—Hypersensitivity—Topotecan—ovarian cancer	0.000449	0.00497	CcSEcCtD
Fidaxomicin—Constipation—Vinorelbine—ovarian cancer	0.000446	0.00493	CcSEcCtD
Fidaxomicin—Immune system disorder—Paclitaxel—ovarian cancer	0.000446	0.00493	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Docetaxel—ovarian cancer	0.000441	0.00488	CcSEcCtD
Fidaxomicin—Hypersensitivity—Melphalan—ovarian cancer	0.00044	0.00486	CcSEcCtD
Fidaxomicin—Vomiting—Chlorambucil—ovarian cancer	0.000435	0.00482	CcSEcCtD
Fidaxomicin—Pruritus—Topotecan—ovarian cancer	0.000431	0.00477	CcSEcCtD
Fidaxomicin—Malnutrition—Paclitaxel—ovarian cancer	0.00043	0.00475	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000426	0.00472	CcSEcCtD
Fidaxomicin—Flatulence—Paclitaxel—ovarian cancer	0.000423	0.00468	CcSEcCtD
Fidaxomicin—Pruritus—Melphalan—ovarian cancer	0.000422	0.00467	CcSEcCtD
Fidaxomicin—Dysgeusia—Paclitaxel—ovarian cancer	0.000421	0.00466	CcSEcCtD
Fidaxomicin—Abdominal pain—Vinorelbine—ovarian cancer	0.000412	0.00456	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	0.000408	0.00451	CcSEcCtD
Fidaxomicin—Nausea—Chlorambucil—ovarian cancer	0.000407	0.0045	CcSEcCtD
Fidaxomicin—Dizziness—Topotecan—ovarian cancer	0.000403	0.00446	CcSEcCtD
Fidaxomicin—Anaemia—Paclitaxel—ovarian cancer	0.000397	0.00439	CcSEcCtD
Fidaxomicin—Angioedema—Paclitaxel—ovarian cancer	0.000393	0.00434	CcSEcCtD
Fidaxomicin—Vomiting—Topotecan—ovarian cancer	0.000387	0.00429	CcSEcCtD
Fidaxomicin—Rash—Topotecan—ovarian cancer	0.000384	0.00425	CcSEcCtD
Fidaxomicin—Hypersensitivity—Vinorelbine—ovarian cancer	0.000384	0.00425	CcSEcCtD
Fidaxomicin—Dermatitis—Topotecan—ovarian cancer	0.000384	0.00425	CcSEcCtD
Fidaxomicin—Headache—Topotecan—ovarian cancer	0.000382	0.00422	CcSEcCtD
Fidaxomicin—Vomiting—Melphalan—ovarian cancer	0.000379	0.0042	CcSEcCtD
Fidaxomicin—Immune system disorder—Docetaxel—ovarian cancer	0.000378	0.00418	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.000377	0.00418	CcSEcCtD
Fidaxomicin—Rash—Melphalan—ovarian cancer	0.000376	0.00416	CcSEcCtD
Fidaxomicin—Dermatitis—Melphalan—ovarian cancer	0.000376	0.00416	CcSEcCtD
Fidaxomicin—Pruritus—Vinorelbine—ovarian cancer	0.000369	0.00408	CcSEcCtD
Fidaxomicin—Malnutrition—Docetaxel—ovarian cancer	0.000364	0.00403	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000363	0.00402	CcSEcCtD
Fidaxomicin—Nausea—Topotecan—ovarian cancer	0.000362	0.004	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.00036	0.00398	CcSEcCtD
Fidaxomicin—Dry mouth—Paclitaxel—ovarian cancer	0.000358	0.00396	CcSEcCtD
Fidaxomicin—Dysgeusia—Docetaxel—ovarian cancer	0.000357	0.00395	CcSEcCtD
Fidaxomicin—Abdominal distension—Epirubicin—ovarian cancer	0.000355	0.00393	CcSEcCtD
Fidaxomicin—Nausea—Melphalan—ovarian cancer	0.000354	0.00392	CcSEcCtD
Fidaxomicin—Dysphagia—Epirubicin—ovarian cancer	0.000352	0.0039	CcSEcCtD
Fidaxomicin—Dizziness—Vinorelbine—ovarian cancer	0.000345	0.00381	CcSEcCtD
Fidaxomicin—Nervous system disorder—Paclitaxel—ovarian cancer	0.000344	0.0038	CcSEcCtD
Fidaxomicin—Skin disorder—Paclitaxel—ovarian cancer	0.000341	0.00377	CcSEcCtD
Fidaxomicin—Anaemia—Docetaxel—ovarian cancer	0.000337	0.00372	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000333	0.00368	CcSEcCtD
Fidaxomicin—Vomiting—Vinorelbine—ovarian cancer	0.000331	0.00367	CcSEcCtD
Fidaxomicin—Neutropenia—Epirubicin—ovarian cancer	0.00033	0.00365	CcSEcCtD
Fidaxomicin—Rash—Vinorelbine—ovarian cancer	0.000329	0.00364	CcSEcCtD
Fidaxomicin—Dermatitis—Vinorelbine—ovarian cancer	0.000328	0.00363	CcSEcCtD
Fidaxomicin—Abdominal distension—Doxorubicin—ovarian cancer	0.000328	0.00363	CcSEcCtD
Fidaxomicin—Headache—Vinorelbine—ovarian cancer	0.000327	0.00361	CcSEcCtD
Fidaxomicin—Dysphagia—Doxorubicin—ovarian cancer	0.000326	0.00361	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Epirubicin—ovarian cancer	0.000318	0.00352	CcSEcCtD
Fidaxomicin—Dyspnoea—Paclitaxel—ovarian cancer	0.000313	0.00346	CcSEcCtD
Fidaxomicin—Nausea—Vinorelbine—ovarian cancer	0.00031	0.00343	CcSEcCtD
Fidaxomicin—Dyspepsia—Paclitaxel—ovarian cancer	0.000309	0.00342	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000308	0.00341	CcSEcCtD
Fidaxomicin—Neutropenia—Doxorubicin—ovarian cancer	0.000305	0.00337	CcSEcCtD
Fidaxomicin—Decreased appetite—Paclitaxel—ovarian cancer	0.000305	0.00337	CcSEcCtD
Fidaxomicin—Dry mouth—Docetaxel—ovarian cancer	0.000303	0.00335	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000303	0.00335	CcSEcCtD
Fidaxomicin—Constipation—Paclitaxel—ovarian cancer	0.0003	0.00332	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000297	0.00329	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000294	0.00326	CcSEcCtD
Fidaxomicin—Nervous system disorder—Docetaxel—ovarian cancer	0.000291	0.00322	CcSEcCtD
Fidaxomicin—Skin disorder—Docetaxel—ovarian cancer	0.000289	0.00319	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000287	0.00317	CcSEcCtD
Fidaxomicin—Abdominal pain—Paclitaxel—ovarian cancer	0.000277	0.00307	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000275	0.00304	CcSEcCtD
Fidaxomicin—Dyspnoea—Docetaxel—ovarian cancer	0.000265	0.00293	CcSEcCtD
Fidaxomicin—Dyspepsia—Docetaxel—ovarian cancer	0.000262	0.00289	CcSEcCtD
Fidaxomicin—Decreased appetite—Docetaxel—ovarian cancer	0.000258	0.00286	CcSEcCtD
Fidaxomicin—Hypersensitivity—Paclitaxel—ovarian cancer	0.000258	0.00286	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000257	0.00284	CcSEcCtD
Fidaxomicin—Immune system disorder—Epirubicin—ovarian cancer	0.000255	0.00282	CcSEcCtD
Fidaxomicin—Constipation—Docetaxel—ovarian cancer	0.000254	0.00281	CcSEcCtD
Fidaxomicin—Pruritus—Paclitaxel—ovarian cancer	0.000248	0.00274	CcSEcCtD
Fidaxomicin—Malnutrition—Epirubicin—ovarian cancer	0.000246	0.00272	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000243	0.00269	CcSEcCtD
Fidaxomicin—Flatulence—Epirubicin—ovarian cancer	0.000242	0.00268	CcSEcCtD
Fidaxomicin—Dysgeusia—Epirubicin—ovarian cancer	0.00024	0.00266	CcSEcCtD
Fidaxomicin—Immune system disorder—Doxorubicin—ovarian cancer	0.000236	0.00261	CcSEcCtD
Fidaxomicin—Abdominal pain—Docetaxel—ovarian cancer	0.000235	0.0026	CcSEcCtD
Fidaxomicin—Dizziness—Paclitaxel—ovarian cancer	0.000232	0.00257	CcSEcCtD
Fidaxomicin—Malnutrition—Doxorubicin—ovarian cancer	0.000227	0.00251	CcSEcCtD
Fidaxomicin—Anaemia—Epirubicin—ovarian cancer	0.000227	0.00251	CcSEcCtD
Fidaxomicin—Flatulence—Doxorubicin—ovarian cancer	0.000224	0.00248	CcSEcCtD
Fidaxomicin—Vomiting—Paclitaxel—ovarian cancer	0.000223	0.00247	CcSEcCtD
Fidaxomicin—Dysgeusia—Doxorubicin—ovarian cancer	0.000223	0.00246	CcSEcCtD
Fidaxomicin—Rash—Paclitaxel—ovarian cancer	0.000221	0.00245	CcSEcCtD
Fidaxomicin—Dermatitis—Paclitaxel—ovarian cancer	0.000221	0.00244	CcSEcCtD
Fidaxomicin—Headache—Paclitaxel—ovarian cancer	0.00022	0.00243	CcSEcCtD
Fidaxomicin—Hypersensitivity—Docetaxel—ovarian cancer	0.000219	0.00242	CcSEcCtD
Fidaxomicin—Pruritus—Docetaxel—ovarian cancer	0.00021	0.00233	CcSEcCtD
Fidaxomicin—Anaemia—Doxorubicin—ovarian cancer	0.00021	0.00232	CcSEcCtD
Fidaxomicin—Nausea—Paclitaxel—ovarian cancer	0.000208	0.0023	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000208	0.0023	CcSEcCtD
Fidaxomicin—Dry mouth—Epirubicin—ovarian cancer	0.000204	0.00226	CcSEcCtD
Fidaxomicin—Nervous system disorder—Epirubicin—ovarian cancer	0.000197	0.00218	CcSEcCtD
Fidaxomicin—Dizziness—Docetaxel—ovarian cancer	0.000197	0.00217	CcSEcCtD
Fidaxomicin—Skin disorder—Epirubicin—ovarian cancer	0.000195	0.00215	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000192	0.00213	CcSEcCtD
Fidaxomicin—Dry mouth—Doxorubicin—ovarian cancer	0.000189	0.00209	CcSEcCtD
Fidaxomicin—Vomiting—Docetaxel—ovarian cancer	0.000189	0.00209	CcSEcCtD
Fidaxomicin—Rash—Docetaxel—ovarian cancer	0.000187	0.00207	CcSEcCtD
Fidaxomicin—Dermatitis—Docetaxel—ovarian cancer	0.000187	0.00207	CcSEcCtD
Fidaxomicin—Headache—Docetaxel—ovarian cancer	0.000186	0.00206	CcSEcCtD
Fidaxomicin—Nervous system disorder—Doxorubicin—ovarian cancer	0.000182	0.00201	CcSEcCtD
Fidaxomicin—Skin disorder—Doxorubicin—ovarian cancer	0.00018	0.00199	CcSEcCtD
Fidaxomicin—Dyspnoea—Epirubicin—ovarian cancer	0.000179	0.00198	CcSEcCtD
Fidaxomicin—Nausea—Docetaxel—ovarian cancer	0.000177	0.00195	CcSEcCtD
Fidaxomicin—Dyspepsia—Epirubicin—ovarian cancer	0.000176	0.00195	CcSEcCtD
Fidaxomicin—Decreased appetite—Epirubicin—ovarian cancer	0.000174	0.00193	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000173	0.00191	CcSEcCtD
Fidaxomicin—Constipation—Epirubicin—ovarian cancer	0.000171	0.0019	CcSEcCtD
Fidaxomicin—Dyspnoea—Doxorubicin—ovarian cancer	0.000165	0.00183	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000164	0.00181	CcSEcCtD
Fidaxomicin—Dyspepsia—Doxorubicin—ovarian cancer	0.000163	0.00181	CcSEcCtD
Fidaxomicin—Decreased appetite—Doxorubicin—ovarian cancer	0.000161	0.00178	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.00016	0.00177	CcSEcCtD
Fidaxomicin—Constipation—Doxorubicin—ovarian cancer	0.000159	0.00175	CcSEcCtD
Fidaxomicin—Abdominal pain—Epirubicin—ovarian cancer	0.000158	0.00175	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000152	0.00168	CcSEcCtD
Fidaxomicin—Hypersensitivity—Epirubicin—ovarian cancer	0.000148	0.00163	CcSEcCtD
Fidaxomicin—Abdominal pain—Doxorubicin—ovarian cancer	0.000147	0.00162	CcSEcCtD
Fidaxomicin—Pruritus—Epirubicin—ovarian cancer	0.000142	0.00157	CcSEcCtD
Fidaxomicin—Hypersensitivity—Doxorubicin—ovarian cancer	0.000137	0.00151	CcSEcCtD
Fidaxomicin—Dizziness—Epirubicin—ovarian cancer	0.000133	0.00147	CcSEcCtD
Fidaxomicin—Pruritus—Doxorubicin—ovarian cancer	0.000131	0.00145	CcSEcCtD
Fidaxomicin—Vomiting—Epirubicin—ovarian cancer	0.000127	0.00141	CcSEcCtD
Fidaxomicin—Rash—Epirubicin—ovarian cancer	0.000126	0.0014	CcSEcCtD
Fidaxomicin—Dermatitis—Epirubicin—ovarian cancer	0.000126	0.0014	CcSEcCtD
Fidaxomicin—Headache—Epirubicin—ovarian cancer	0.000126	0.00139	CcSEcCtD
Fidaxomicin—Dizziness—Doxorubicin—ovarian cancer	0.000123	0.00136	CcSEcCtD
Fidaxomicin—Nausea—Epirubicin—ovarian cancer	0.000119	0.00132	CcSEcCtD
Fidaxomicin—Vomiting—Doxorubicin—ovarian cancer	0.000118	0.0013	CcSEcCtD
Fidaxomicin—Rash—Doxorubicin—ovarian cancer	0.000117	0.00129	CcSEcCtD
Fidaxomicin—Dermatitis—Doxorubicin—ovarian cancer	0.000117	0.00129	CcSEcCtD
Fidaxomicin—Headache—Doxorubicin—ovarian cancer	0.000116	0.00129	CcSEcCtD
Fidaxomicin—Nausea—Doxorubicin—ovarian cancer	0.00011	0.00122	CcSEcCtD
